| abstract |
Formula (I) [Wherein R 1 , R 2 , X, Y and Z are as defined herein] A therapeutically active anthranilic acid derivative represented by the formula, a process for preparing the derivative, a pharmaceutical formulation containing the active compound, treatment, in particular, insufficient activation of the HM74A receptor contributes to the disease, or Disclosed is the use of the compounds in the treatment of diseases where activation is beneficial. |